New insights into the biology and pathology of the cutaneous lymphatic system

Journal of Dermatological Science

Volumn 35, Issue 1, 2004, Pages 1-8

  Hirakawa, Satoshi ^a   Detmar, Michael ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Lymphangiogenesis; LYVE 1; Prox1; VEGF; VEGF C

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; HUMAN; IMMUNE RESPONSE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC SYSTEM; LYMPHEDEMA; METASTASIS; MILROY DISEASE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN STRUCTURE; TISSUE WATER;

ANIMALS; BIOLOGICAL MARKERS; ENDOTHELIAL GROWTH FACTORS; HOMEOSTASIS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; LYMPHEDEMA; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2942576148     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2003.10.006     Document Type: Review

References (47)

1. Oliver G., Detmar M. The rediscovery of the lymphatic system. Genes Dev. 16:2002;773-783
2. Gale N.W., Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13:1999;1055-1066
3. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell. 1:2002;219-227
4. Detmar M., Hirakawa S. The formation of lymphatic vessels and its importance in the setting of malignancy. J. Exp. Med. 6:2002;713-718
5. Asellius G, De lactibus sive lacteis venis. Milan: Mediolani; 1627.
6. Sabin F.R. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am. J. Anat. 1:1902;367-391
7. Huntington G.S., McClure C.F.W. The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Am. J. Anat. 10:1910;177-311
8. Wigle J.T., Harvey N., Detmar M., Lagutina I., Grosveld G., Gunn M.D., et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21:2002;1505-1513
9. Nagy J.A., Vasile E., Feng D., Sundberg C., Brown L.F., Detmar M.J., et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 196:2002;1497-1506
10. Jussila L., Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82:2002;673-700
11. Maekinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7:2001;199-205
12. Kaipainen A., Korhonen J., Mustonen T., van H.V., Fang G.H., Dumont D., et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. U.S.A. 92:1995;3566-3570
13. Jeltsch M., Kaipainen A., Joukov V., Kukk E., Lymbousssaki A.X.M., Lakso M., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 276:1997;1423-1425
14. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 282:1998;946-949
15. Karkkainen M.J., Ferrell R.E., Lawrence E.C., Kimak M.A., Levinson K.L., McTigue M.A., et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25:2000;153-159
16. Paavonen K., Puolakkainen P., Jussila L., Jahkola T., Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 156:2000;1499-1504
17. Valtola R., Salven P., Heikkila P., Taipale J., Joensuu H., Rehn M., et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154:1999;1381-1390
18. Wigle J.T., Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 98:1999;769-778
19. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144:1999;789-801
20. Prevo R., Banerji S., Ferguson D.J., Clasper S., Jackson D.G. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276:2001;19420-19430
21. Skobe M., Detmar M. Structure. J. Invest. Dermatol. Symp. Proc. 5:2000;14-19
22. Gunn M.D., Tangemann K., Tam C., Cyster J.G., Rosen S.D., Williams L.T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 95:1998;258-263
23. Schacht V., Ramirez M.I., Hong Y.K., Hirakawa S., Feng D., Harvey N., et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22:2003;3546-3556
24. Ebata N., Nodasaka Y., Sawa Y., Yamaoka Y., Makino S., Totsuka Y., et al. Desmoplakin as a specific marker of lymphatic vessels. Microvasc. Res. 61:2001;40-48
25. Yuan L., Moyon D., Pardanaud L., Breant C., Karkkainen M.J., Alitalo K., et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development. 129:2002;4797-4806
26. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain C., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev. Cell. 3:2002;411-423
27. Kriehuber E., Breiteneder G.S., Groeger M., Soleiman A., Schoppmann S.F., Stingl G., et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194:2001;797-808
28. Petrova T.V., Maekinen T., Maekelae T.P., Saarela J., Virtanen I., Ferrell R.E., et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21:2002;4593-4599
29. Maekinen T., Veikkola T., Mustjoki S., Karpanen T., Catimel B., Nice E.C., et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20:2001;4762-4773
30. Hirakawa S., Hong Y.K., Harvey N., Schacht V., Matsuda K., Libermann T., et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol. 162:2003;575-586
31. Witte M.H., Bernas M.J., Martin C.P., Witte C.L. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc. Res. Technol. 55:2001;122-145
32. Ferrell R.E., Levinson K.L., Esman J.H., Kimak M.A., Lawrence E.C., Barmada M.M., et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum. Mol. Genet. 7:1998;2073-2078
33. Evans A.L., Brice G., Sotirova V., Mortimer P., Beninson J., Burnand K., et al. Mapping of primary congenital lymphedema to the 5q35.3 region. Am. J. Hum. Genet. 64:1999;547-555
34. Karkkainen M.J., Saaristo A., Jussila L., Karila K.A., Lawrence E.C., Pajusola K., et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12677-12682
35. Fang J., Dagenais S.L., Erickson R.P., Arlt M.F., Glynn M.W., Gorski J.L., et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67:2000;1382-1388
36. Irrthum A., Devriendt K., Chitayat D. Mutations in the transcription factor gene SOX18 underlie recesive and dominant forms of hypothrichosis- lymphedema-teleangeactasia. Am. J. Hum. Genet. 72:2003;1470-1478
37. Huang X.Z., Wu J.F., Ferrando R., Lee J.H., Wang Y.L., Farese R.V. Jr., et al. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell Biol. 20:2000;5208-5215
38. Saaristo A., Veikkola T., Tammela T., Enholm B., Karkkainen M.J., Pajusola K., et al. Lymphangiogenic gene therapy with minimal blood vascular side-effects. J. Exp. Med. 196:2002;719-730
39. Szuba A., Skobe M., Karkkainen M.J., Shin W.S., Beynet D.P., Rockson N.B., et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16:2002;1985-1987
40. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257
41. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7:2001;192-198
42. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7:2001;186-191
43. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20:2001;672-682
44. Karpanen T., Egeblad M., Karkkainen M.J., Kubo H., Yla-Herttuala S., Jaattela M., et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61:2001;1786-1790
45. He Y., Kozaki K., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94:2002;819-825
46. Stacker S.A., Baldwin M.E., Achen M.G. The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 16:2002;922-934
47. Dadras S.S., Paul T., Bertoncini J., Brown L.F., Muzikansky A., Jackson D.G., et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am. J. Pathol. 162:2003;1951-1960